A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors

AIMS: Clopidogrel and angiotensin converting enzyme (ACE) inhibitors are commonly co-prescribed drugs. Clopidogrel inhibits carboxylesterase 1 (CES1), the enzyme responsible for converting prodrug ACE inhibitors (such as ramipril and perindopril) to their active metabolites. The clinical implication...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Clin Pharmacol
Glavni autori: Cressman, Alex M, Macdonald, Erin M, Fernandes, Kimberly A, Gomes, Tara, Paterson, J Michael, Mamdani, Muhammad M, Juurlink, David N
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2015
Teme:
Pharmacoepidemiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4594702/
https://ncbi.nlm.nih.gov/pubmed/25980448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12682
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items